Search Results - "D’agostini, T."

Refine Results
  1. 1

    Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients by Ehlken, Christoph, Helms, Mandy, Böhringer, Daniel, Agostini, Hansjürgen T, Stahl, Andreas

    Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2018)
    “…Real-life clinical outcomes of patients treated with anti-VEGF drugs for neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), or…”
    Get full text
    Journal Article
  2. 2

    Gene expression profiling in a mouse model of retinal vein occlusion induced by laser treatment reveals a predominant inflammatory and tissue damage response by Martin, Gottfried, Conrad, David, Cakir, Bertan, Schlunck, Günther, Agostini, Hansjürgen T

    Published in PloS one (12-03-2018)
    “…Retinal vein occlusion (RVO) has been investigated in several laser-induced animal models using pigs, rabbits and rats. However, laser-induced RVO has been…”
    Get full text
    Journal Article
  3. 3

    Viral S protein histochemistry reveals few potential SARS-CoV-2 entry sites in human ocular tissues by Martin, Gottfried, Wolf, Julian, Lapp, Thabo, Agostini, Hansjürgen T., Schlunck, Günther, Auw-Hädrich, Claudia, Lange, Clemens A. K.

    Published in Scientific reports (27-09-2021)
    “…Despite the reported low expression of the primary SARS-CoV-2 receptor ACE2 in distinct ocular tissues, some clinical evidence suggests that SARS-CoV-2 can…”
    Get full text
    Journal Article
  4. 4

    Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion by Ehlken, Christoph, Grundel, Bastian, Michels, Daniel, Junker, Bernd, Stahl, Andreas, Schlunck, Günther, Hansen, Lutz L, Feltgen, Nicolas, Martin, Gottfried, Agostini, Hansjürgen T, Pielen, Amelie

    Published in PloS one (15-05-2015)
    “…Central retinal vein occlusion (CRVO) is a common disease characterized by a disrupted retinal blood supply and a high risk of subsequent vision loss due to…”
    Get full text
    Journal Article
  5. 5

    Methylglyoxal and high glucose inhibit VEGFR2 phosphorylation at specific tyrosine residues by Betting, Fabian, Schlunck, Günther, Agostini, Hansjürgen T., Martin, Gottfried

    “…Diabetes is characterized by hyperglycemia and a significant risk of vascular complications. Vascular endothelial growth factor (VEGF) and its main receptor…”
    Get full text
    Journal Article
  6. 6

    Simultaneous Rhinoseptoplasty and Orthognathic Surgery: Outcome Analysis of 250 Consecutive Patients Using a Modified Le Fort I Osteotomy by Raffaini, M., Cocconi, R., Spinelli, G., Agostini, T.

    Published in Aesthetic plastic surgery (01-08-2018)
    “…Background The purpose of the present study was to assess the safety and efficacy of both functional intranasal procedures and cosmetic rhinoplasty combined…”
    Get full text
    Journal Article
  7. 7

    A safety review and meta-analyses of bevacizumab and ranibizumab: off-label versus goldstandard by Schmucker, Christine, Ehlken, Christoph, Agostini, Hansjuergen T, Antes, Gerd, Ruecker, Gerta, Lelgemann, Monika, Loke, Yoon K

    Published in PloS one (03-08-2012)
    “…We set out a systemic review to evaluate whether off-label bevacizumab is as safe as licensed ranibizumab, and whether bevacizumab can be justifiably offered…”
    Get full text
    Journal Article
  8. 8

    Hyperoxia causes reduced density of retinal astrocytes in the central avascular zone in the mouse model of oxygen-induced retinopathy by Bucher, Felicitas, Stahl, Andreas, Agostini, Hansjürgen T., Martin, Gottfried

    Published in Molecular and cellular neuroscience (01-09-2013)
    “…The mouse model of oxygen-induced retinopathy (OIR) is commonly used to investigate various aspects of the pathogenesis of the retinopathy of prematurity (ROP)…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Arteriovenous crossing in retinal vessels of mice, rats, and pigs by Martin, Gottfried, Wefelmeyer, Kira L, Bucher, Felicitas, Schlunck, Günther, Agostini, Hansjürgen T

    Published in Molecular vision (15-10-2020)
    “…Retinal vein occlusions (RVOs) are a common disease, but there are no animal models for spontaneous RVO formation. The critical sites of predilection,…”
    Get full text
    Journal Article
  12. 12

    Activation of retinal microglia rather than microglial cell density correlates with retinal neovascularization in the mouse model of oxygen-induced retinopathy by Fischer, Franziska, Martin, Gottfried, Agostini, Hansjürgen T

    Published in Journal of neuroinflammation (23-09-2011)
    “…Retinal neovascularization has been intensively investigated in the mouse model of oxygen-induced retinopathy (OIR). Here, we studied the contribution of…”
    Get full text
    Journal Article
  13. 13

    Levels of VEGF but not VEGF165b are Increased in the Vitreous of Patients With Retinal Vein Occlusion by Ehlken, Christoph, Rennel, Emma S, Michels, Daniel, Grundel, Bastian, Pielen, Amelie, Junker, Bernd, Stahl, Andreas, Hansen, Lutz L, Feltgen, Nicolas, Agostini, Hansjürgen T, Martin, Gottfried

    Published in American journal of ophthalmology (01-08-2011)
    “…Purpose To determine the concentration of the pro-angiogenic vascular endothelial growth factor VEGF165 (VEGF) and the anti-angiogenic VEGF165b in vitreous…”
    Get full text
    Journal Article
  14. 14

    Semaphorin 3F forms an anti-angiogenic barrier in outer retina by Buehler, Anima, Sitaras, Nicholas, Favret, Sandra, Bucher, Felicitas, Berger, Stefanie, Pielen, Amelie, Joyal, Jean-Sebastian, Juan, Aimee M., Martin, Gottfried, Schlunck, Guenther, Agostini, Hansjürgen T., Klagsbrun, Michael, Smith, Lois E.H., Sapieha, Przemyslaw, Stahl, Andreas

    Published in FEBS letters (05-06-2013)
    “…•The outer retina is physiologically avascular.•Sema3F is expressed almost exclusively in photoreceptors and RPE of the outer retina.•Sema3F inhibits sprouting…”
    Get full text
    Journal Article
  15. 15

    Closed reduction of the isolated anterior frontal sinus fracture via percutaneous screw placement by Spinelli, G, Lazzeri, D, Arcuri, F, Agostini, T

    “…Abstract Fractures of the frontal sinus are a common maxillofacial trauma and constitute 5–15% of all maxillofacial fractures. Conventional surgical approaches…”
    Get full text
    Journal Article
  16. 16

    Value of Optical Coherence Tomography Angiography Imaging in Diagnosis and Treatment of Hemangioblastomas in von Hippel-Lindau Disease by Lang, Stefan J, Cakir, Bertan, Evers, Charlotte, Ludwig, Franziska, Lange, Clemens A K, Agostini, Hansjürgen T

    “…The introduction of optical coherence tomography angiography (OCTA) provides new insights into the retinal vasculature. The aim of this study was to explore…”
    Get more information
    Journal Article
  17. 17

    Potential selection bias in candidates for stereotactic radiotherapy for neovascular AMD by Ehlken, Christoph, Böhringer, Daniel, Agostini, Hansjürgen T., Grundel, Bastian, Stech, Milena

    “…Purpose Stereotactic radiotherapy (SRT, IRay) was able to reduce the need for intravitreal injections of anti-VEGF (IVI) in patients with neovascular AMD…”
    Get full text
    Journal Article
  18. 18

    Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications by Stahl, Andreas, Stumpp, Michael T., Schlegel, Anja, Ekawardhani, Savira, Lehrling, Christina, Martin, Gottfried, Gulotti-Georgieva, Maya, Villemagne, Denis, Forrer, Patrik, Agostini, Hansjürgen T., Binz, H. Kaspar

    Published in Angiogenesis (London) (01-01-2013)
    “…The next-generation ophthalmic anti-VEGF therapeutics must aim at being superior to the currently available agents with regard to potency and improved drug…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review by Schmucker, Christine, Loke, Yoon K, Ehlken, Christoph, Agostini, Hansjuergen T, Hansen, Lutz L, Antes, Gerd, Lelgemann, Monika

    Published in British journal of ophthalmology (01-03-2011)
    “…To conduct a systematic review in order to compare adverse effects (AE) and the reporting of harm in randomised controlled trials (RCTs) and non-RCTs…”
    Get more information
    Journal Article